Global Molecular Diagnostics and NAT Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 123 pages | ID: G38D302F1BAGEN
GlobalInfoResearch

Abstracts

Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.

SCOPE OF THE REPORT:

This report studies the Molecular Diagnostics and NAT market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics and NAT market by product type and applications/end industries.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
The global Molecular Diagnostics and NAT market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics and NAT.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Roche
• Abbott
• BD
• Biomerieux
• Qiagen
• Thermo Fisher Scientific
• Agilent
• GenMark
• Siemens Healthcare
• AutoGenomics

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Amplification Technologies
• Amplified Gene Detection Technologies
• DNA And Oligonucleotide Microarrays
• Gene Sequencing

Market Segment by Applications, can be divided into

• Hospitals and Clinics
• Research Institutes
• Diagnostic Centers

Contents

1 MOLECULAR DIAGNOSTICS AND NAT MARKET OVERVIEW

1.1 Product Overview and Scope of Molecular Diagnostics and NAT
1.2 Classification of Molecular Diagnostics and NAT by Types
  1.2.1 Global Molecular Diagnostics and NAT Revenue Comparison by Types (2017-2023)
  1.2.2 Global Molecular Diagnostics and NAT Revenue Market Share by Types in 2017
  1.2.3 Amplification Technologies
  1.2.4 Amplified Gene Detection Technologies
  1.2.5 DNA And Oligonucleotide Microarrays
  1.2.6 Gene Sequencing
1.3 Global Molecular Diagnostics and NAT Market by Application
  1.3.1 Global Molecular Diagnostics and NAT Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals and Clinics
  1.3.3 Research Institutes
  1.3.4 Diagnostic Centers
1.4 Global Molecular Diagnostics and NAT Market by Regions
  1.4.1 Global Molecular Diagnostics and NAT Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.5 Global Market Size of Molecular Diagnostics and NAT (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Molecular Diagnostics and NAT Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
  2.2.1 Business Overview
  2.2.2 Molecular Diagnostics and NAT Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Abbott Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.3 BD
  2.3.1 Business Overview
  2.3.2 Molecular Diagnostics and NAT Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 BD Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biomerieux
  2.4.1 Business Overview
  2.4.2 Molecular Diagnostics and NAT Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Biomerieux Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.5 Qiagen
  2.5.1 Business Overview
  2.5.2 Molecular Diagnostics and NAT Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Qiagen Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
  2.6.1 Business Overview
  2.6.2 Molecular Diagnostics and NAT Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.7 Agilent
  2.7.1 Business Overview
  2.7.2 Molecular Diagnostics and NAT Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Agilent Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.8 GenMark
  2.8.1 Business Overview
  2.8.2 Molecular Diagnostics and NAT Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 GenMark Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens Healthcare
  2.9.1 Business Overview
  2.9.2 Molecular Diagnostics and NAT Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Siemens Healthcare Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.10 AutoGenomics
  2.10.1 Business Overview
  2.10.2 Molecular Diagnostics and NAT Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 AutoGenomics Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MOLECULAR DIAGNOSTICS AND NAT MARKET COMPETITION, BY PLAYERS

3.1 Global Molecular Diagnostics and NAT Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Molecular Diagnostics and NAT Players Market Share
  3.2.2 Top 10 Molecular Diagnostics and NAT Players Market Share
3.3 Market Competition Trend

4 GLOBAL MOLECULAR DIAGNOSTICS AND NAT MARKET SIZE BY REGIONS

4.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.3 Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.5 South America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MOLECULAR DIAGNOSTICS AND NAT REVENUE BY COUNTRIES

5.1 North America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
5.2 USA Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
5.3 Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
5.4 Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

6 EUROPE MOLECULAR DIAGNOSTICS AND NAT REVENUE BY COUNTRIES

6.1 Europe Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
6.2 Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.3 UK Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.4 France Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.5 Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.6 Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MOLECULAR DIAGNOSTICS AND NAT REVENUE BY COUNTRIES

7.1 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
7.2 China Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.3 Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.4 Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.5 India Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MOLECULAR DIAGNOSTICS AND NAT REVENUE BY COUNTRIES

8.1 South America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
8.2 Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
8.3 Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
8.4 Colombia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MOLECULAR DIAGNOSTICS AND NAT BY COUNTRIES

9.1 Middle East and Africa Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
9.2 Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.3 UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.4 Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.5 Nigeria Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.6 South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)

10 GLOBAL MOLECULAR DIAGNOSTICS AND NAT MARKET SEGMENT BY TYPE

10.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Type (2013-2018)
10.2 Global Molecular Diagnostics and NAT Market Forecast by Type (2018-2023)
10.3 Amplification Technologies Revenue Growth Rate (2013-2023)
10.4 Amplified Gene Detection Technologies Revenue Growth Rate (2013-2023)
10.5 DNA And Oligonucleotide Microarrays Revenue Growth Rate (2013-2023)
10.6 Gene Sequencing Revenue Growth Rate (2013-2023)

11 GLOBAL MOLECULAR DIAGNOSTICS AND NAT MARKET SEGMENT BY APPLICATION

11.1 Global Molecular Diagnostics and NAT Revenue Market Share by Application (2013-2018)
11.2 Molecular Diagnostics and NAT Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Research Institutes Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 GLOBAL MOLECULAR DIAGNOSTICS AND NAT MARKET SIZE FORECAST (2018-2023)

12.1 Global Molecular Diagnostics and NAT Market Size Forecast (2018-2023)
12.2 Global Molecular Diagnostics and NAT Market Forecast by Regions (2018-2023)
12.3 North America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.4 Europe Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.6 South America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Molecular Diagnostics and NAT Picture
Table Product Specifications of Molecular Diagnostics and NAT
Table Global Molecular Diagnostics and NAT and Revenue (Million USD) Market Split by Product Type
Figure Global Molecular Diagnostics and NAT Revenue Market Share by Types in 2017
Figure Amplification Technologies Picture
Figure Amplified Gene Detection Technologies Picture
Figure DNA And Oligonucleotide Microarrays Picture
Figure Gene Sequencing Picture
Table Global Molecular Diagnostics and NAT Revenue (Million USD) by Application (2013-2023)
Figure Molecular Diagnostics and NAT Revenue Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Research Institutes Picture
Figure Diagnostic Centers Picture
Table Global Market Molecular Diagnostics and NAT Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Molecular Diagnostics and NAT Type and Applications
Table Roche Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Molecular Diagnostics and NAT Type and Applications
Table Abbott Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Molecular Diagnostics and NAT Type and Applications
Table BD Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Biomerieux Basic Information, Manufacturing Base and Competitors
Table Biomerieux Molecular Diagnostics and NAT Type and Applications
Table Biomerieux Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Molecular Diagnostics and NAT Type and Applications
Table Qiagen Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Molecular Diagnostics and NAT Type and Applications
Table Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Molecular Diagnostics and NAT Type and Applications
Table Agilent Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table GenMark Basic Information, Manufacturing Base and Competitors
Table GenMark Molecular Diagnostics and NAT Type and Applications
Table GenMark Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Molecular Diagnostics and NAT Type and Applications
Table Siemens Healthcare Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table AutoGenomics Basic Information, Manufacturing Base and Competitors
Table AutoGenomics Molecular Diagnostics and NAT Type and Applications
Table AutoGenomics Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
Table Global Molecular Diagnostics and NAT Revenue (Million USD) by Players (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue Share by Players (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Share by Players in 2016
Figure Global Molecular Diagnostics and NAT Revenue Share by Players in 2017
Figure Global Top 5 Players Molecular Diagnostics and NAT Revenue Market Share in 2017
Figure Global Top 10 Players Molecular Diagnostics and NAT Revenue Market Share in 2017
Figure Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue (Million USD) by Regions (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue Market Share by Regions (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Market Share by Regions (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Market Share by Regions in 2017
Figure North America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure South America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table North America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
Table North America Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure North America Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure North America Molecular Diagnostics and NAT Revenue Market Share by Countries in 2017
Figure USA Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table Europe Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2013-2018)
Figure Europe Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure Europe Molecular Diagnostics and NAT Revenue Market Share by Countries in 2017
Figure Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure UK Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure France Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Molecular Diagnostics and NAT Revenue Market Share by Countries in 2017
Figure China Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure India Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table South America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
Table South America Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure South America Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure South America Molecular Diagnostics and NAT Revenue Market Share by Countries in 2017
Figure Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Colombia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Molecular Diagnostics and NAT Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Molecular Diagnostics and NAT Revenue Market Share by Countries in 2017
Figure Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure Nigeria Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Figure South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue (Million USD) by Type (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue Share by Type (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Share by Type (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Share by Type in 2017
Table Global Molecular Diagnostics and NAT Revenue Forecast by Type (2018-2023)
Figure Global Molecular Diagnostics and NAT Market Share Forecast by Type (2018-2023)
Figure Global Amplification Technologies Revenue Growth Rate (2013-2018)
Figure Global Amplified Gene Detection Technologies Revenue Growth Rate (2013-2018)
Figure Global DNA And Oligonucleotide Microarrays Revenue Growth Rate (2013-2018)
Figure Global Gene Sequencing Revenue Growth Rate (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue by Application (2013-2018)
Table Global Molecular Diagnostics and NAT Revenue Share by Application (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Share by Application (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue Share by Application in 2017
Table Global Molecular Diagnostics and NAT Revenue Forecast by Application (2018-2023)
Figure Global Molecular Diagnostics and NAT Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Molecular Diagnostics and NAT Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Molecular Diagnostics and NAT Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Molecular Diagnostics and NAT Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
Figure Europe Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
Figure South America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)